Combination of fluoxetine and extinction treatments forms a unique synaptic protein profile that correlates with long-term fear reduction in adult mice by Popova, Dina et al.
1 
 
Combination of fluoxetine and extinction treatments forms a unique synaptic proteins 
profile that correlates with long-term fear reduction in adult mice 
European Neuropsychopharmacology (2014) 24, 1162–1174 
http://dx.doi.org/10.1016/j.euroneuro.2014.04.002 
 
Dina Popova, Arna Ágústsdóttir, Jesse Lindholm, Ulams Mazulis, Yumiko Akamine, Eero 
Castrén, Nina N. Karpova *. 
Neuroscience Center, University of Helsinki, P.O. Box 56, 00790 Helsinki, Finland 
Tel: +358919157629; Fax: +358919157620 
 
* To whom correspondence should be addressed: Nina N. Karpova, E-mail: 
nina.karpova@helsinki.fi or nina.karpova@gmail.com 
 
 
KEYWORDS 
Fluoxetine; Fear conditioning; Extinction; Neuronal plasticity; Inhibitory and excitatory 
transmissions; Presynaptic and postsynaptic protein markers 
Abstract 
Abstract: The antidepressant fluoxetine induces synaptic plasticity in the visual and fear networks and promotes 
the structural remodeling of neuronal circuits, which is critical for experience-dependent plasticity in response to 
an environmental stimulus. We recently demonstrated that chronic fluoxetine administration together with 
extinction training in adult mice reduced fear in a context-independent manner. Fear conditioning and extinction 
alter excitatory and inhibitory transmissions within the fear circuitry. In this study, we investigated whether 
fluoxetine, extinction or their combination produced distinct long-lasting changes in the synaptic protein profile in 
the amygdala, hippocampus and prefrontal cortex of conditioned mice. We determined that extinction induced 
synaptophysin expression and down-regulated the GluA1:GluA2 ratio throughout the fear network in water- and 
fluoxetine-treated mice, suggesting a common fluoxetine-independent mechanism for increased synaptic 
transmission and re-arrangement of AMPA-receptors by extinction training. In contrast to common changes, the 
presynaptic vesicular neurotransmitter transporters VGAT and Vglut1 were upregulated after extinction in water- 
and fluoxetine-treated mice, respectively. The cortical levels of the GABA transporter Gat1 were reduced in high-
freezing water-drinking mice, suggesting a maladaptive increase of GABA spillover at cortical inhibitory 
synapses. Fear conditioning decreased, and extinction induced the expression of GABA-receptor alpha1 and 
alpha2 subunits in water- and fluoxetine-treated mice, respectively. Only a combination of fluoxetine with 
extinction enhanced GluN2A expression in the amygdala and hippocampus, emphasizing the role of this NMDA-
receptor subunit in the successful erasure of fear memories. Our finding provides novel data that may become 
helpful in developing beneficial pharmacological fear-reducing treatment strategies. 
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1. Introduction 
Fear conditioning and extinction paradigm is a widely accepted model for anxiety disorders 
and cognitive behavioral therapies. Although the model does not cover all symptoms of 
anxiety disorders, the model might help to examine the efficacy of extinction training in 
transgenic animals or in combination with pharmacological compounds. The extinction-
enhancing treatments that have beneficial effects on the long-term reduction of the 
expression of pathological fear memory in different contexts are essential for anti-anxiety 
therapies. Several studies have aimed to understand the neurobiological processes that 
mediate the facilitation of extinction. Accumulating evidence implicates the amygdala, the 
hippocampus and the infralimbic and prelimbic areas of the medial prefrontal cortex in the 
expression of fear responses (Quirk et al., 2010). Because both fear acquisition and 
extinction alter synaptic transmission in these brain areas at excitatory and inhibitory 
synapses (Ehrlich et al., 2009; Lange et al., 2012), dissecting the synaptic mechanisms of 
fear reduction through the enhancement of extinction memories is necessary.  
Pharmacological agents that potentiate or inhibit the function of proteins involved in synaptic 
transmission represent one of the most valuable tools for elucidating the molecular 
mechanisms of extinction facilitation. Over the past decade, D-cycloserine, a partial agonist 
of the N-methyl-D-aspartate receptor (NMDAR) has been consistently shown to enhance 
fear extinction learning and reduce several, although not all, anxiety symptoms (Walker et 
al., 2002; Mao et al., 2006; Guastella et al., 2007). Another important group of compounds 
are benzodiazepines, agonists of the gamma-aminobutyric acid A receptors (GABA(A)Rs) 
that have recently been shown to reduce fear potentiated startle responses (Smith et al., 
2012). However, the beneficial effect of benzodiazepines seems to be context-dependent, 
thus reducing their clinical value (Harris and Westbrook, 2001; Otto et al., 2005). Acute 
treatment with diazepam before extinction training could prevent extinction retention in a 
shuttle avoidance task potentially due to the induction of anterograde amnesia (Pereira et 
al., 1989). Another limitation of  benzodiazepines is the development of dependence in case 
of chronic treatment (Wolf and Griffiths, 1991). Finally, a critical function of the 
antidepressant group of pharmacological compounds, in particular serotonin-selective 
reuptake inhibitors (SSRIs) in synaptic plasticity and fear memory is currently under 
intensive investigation. Not all SSRIs were found to have the potential for a beneficial 
outcome on the combined treatment (Burghardt et al., 2013). The diverse effects of SSRIs 
are thought to be a result of their different affinity to the serotonin transporter (Owens and 
Nemeroff, 1998) and selectivity in potentiating various neurotransmitters (Goodnick and 
Goldstein, 1998). The SSRI fluoxetine has consistently been shown to facilitate extinction 
learning and retention and long-term context-independent fear reduction in rodents (Karpova 
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et al., 2011; Camp et al., 2012) and has been shown to significantly reduce fear 
reinstatement even after discontinuation of fluoxetine exposure (Deschaux et al., 2011). 
However, the synaptic mechanisms of these effects are largely unstudied.  
The trafficking of the α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate receptors 
(AMPARs) is critically involved in the plasticity of excitatory synapses and the GluA1-
dependent synaptic removal of GluA2-containing calcium-permeable AMPARs during 
extinction was shown to promote long-term depression in the lateral amygdala and fear 
memory erasure (Kim et al., 2007; Clem and Huganir, 2010). The GluA1-subunit of calcium-
impermeable AMPARs has been recently found to be up-regulated in the basolateral 
amygdala shortly after the spontaneous fear recovery and context-dependent fear renewal 
tests (Xue et al., 2014). The key markers of the GABAergic system (different GABA(A)R 
subunits, GABA plasma membrane transporter-1 Gat1 and gephyrin) are dynamically 
regulated in the amygdala nuclei by the fear conditioning and/or extinction: the mRNA 
expression analysis revealed that the GABAergic markers were primarily down-regulated 
right after fear conditioning and up-regulated following fear extinction training (Chhatwal et 
al., 2005; Heldt and Ressler, 2007). Accordingly, the surface expression of the GABA(A)R 
β3 and γ2 subunits was decreased by the conditioning and increased by the extinction in the 
lateral amygdala (Lin et al., 2009). However, limited data exist on the fear 
conditioning/extinction-induced synaptic protein expression outside the amygdala and on the 
long-lasting effects of the accelerated extinction on synaptic protein changes associated with 
efficient fear erasure. Such data are of particular importance for developing effective 
pharmacological strategies in those clinical cases when the immediate behavioral or 
pharmacological therapies are not applicable.  
We have recently shown that chronic fluoxetine applied before and during fear extinction 
training had a long-term effect on extinction acceleration and fear erasure in adult mice 
(Karpova et al., 2011). The aim of the present study was to use the same protocol for 
simultaneous analysis of the fear responses and of the synaptic proteins profile permissive 
for long-term fear reduction in mice. We applied an immunohistochemical approach to 
provide spatial specificity of protein expression by outlining the brain areas critical for fear 
memory: the prelimbic and infralimbic cortices, the basolateral, lateral and central amygdala 
nuclei and the CA1 region of hippocampus. We evaluated how the combination of fluoxetine 
treatment and extinction training affected long-term expression of the markers of excitatory 
and inhibitory transmission: the presynaptic synaptophysin Syp, vesicular glutamate 
transporter Vglut1, vesicular GABA and glycine transporter VGAT, GABA transporter Gat1, 
and the postsynaptic major GABA(A)R subunits α1 and α2, postsynaptic density protein 
PSD95, as well as the major components of glutamate receptors (NMDARs subunit GluN2A 
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and AMPARs subunits GluA1 and GluA2). Our results provide evidence that a combination 
of chronic fluoxetine and extinction training forms unique long-lasting synaptic protein 
patterns in the fear network of conditioned mice compared with either treatment alone.  
 
2. Experimental Procedures 
2.1. Animals 
Adult male mice C57Bl/6JRcc.Hsd (Harlan, Netherlands) were housed individually for 7 days 
prior to fear conditioning and were 3 months old at the time of fear conditioning. Mice were 
kept under a 12 h light/dark cycle (light on at 6 am). Food and water were available ad 
libitum. All animal procedures were done according to the guidelines of the National Institute 
of Health Guide for the Care and Use of Laboratory Animals and were approved by the 
experimental Animal Ethical Committee of Southern Finland. 
2.2. Drug treatment 
Non-invasive approach of drug administration was used. Mice received fluoxetine (kind gift 
from Dr. Jukka Sallinen, Orion Pharma, Helsinki, Finland) via drinking water in light-
protected tubes. Solutions were prepared fresh every day. Fluoxetine was dissolved in tap 
water at a concentration of 0.08 mg/ml. With this concentration, the fluid consumption level 
was not affected (Fig. S1) and the mean fluoxetine dosing was 10.26±0.13 mg/kg per day. 
This protocol of chronic fluoxetine administration to adult mice was reported to results in 
clinically relevant plasma fluoxetine levels (Dulawa et al., 2004; Rantamaki et al., 2007) and 
to effectively produce behavioral alterations in depression- and anxiety-like behaviors 
(Karpova et al., 2009; Karpova et al., 2011).  
2.3. Fear conditioning 
Fear conditioning took place in the context A (a transparent Plexiglas chamber with metal 
grids that was cleaned before each session with 70 % ethanol). Freezing behavior was 
measured with an automatic infrared beam detection system which was placed on the sides 
of the fear conditioning chamber of (TSE Systems GmbH, Germany). The mouse was 
considered to be frozen only if it was not moving for at least 3 s, and the measure was 
expressed as a percentage of time spent freezing. Every mouse was handled in the 
experimental room for 5-10 minutes during each of the 3 days prior to fear conditioning. On 
the day of fear acquisition, mice were exposed to context A for 2 minutes and conditioned 
using 5 pairings of the CS (Conditioned Stimulus; total duration 30 s, 1 Hz, white noise, 80 
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dB) with the US (Unconditioned Stimulus; 1 s foot-shock 0.6 mA, inter-trial interval: 20-120 
s). The US co-terminated with the CS. The freezing level during the first CS, preceding the 
first US, was taken as the baseline freezing during CS. Mice were then divided into four 
groups (two extinction, FC+WAT+EXT and FC+FLX+EXT, and two no-extinction, FC+WAT 
and FC+FLX, groups) with equal levels of freezing, two receiving fluoxetine in their drinking 
water until the end of the experiment and the other two receiving tap water. For the control 
group CTRL, mice were subjected to the same fear conditioning experimental protocol 
except that the CS was not followed by the US (non-conditioned, only context + CS 
exposure group); then, the CTRL mice received tap water. Two weeks after the fear 
conditioning day, the mice from the CTRL and both no-extinction groups (n=6 per group) 
were sacrificed for subsequent immunohistochemical analysis.  
2.4. Fear extinction training, spontaneous recovery and fear renewal  
Two-day fear extinction training took place 2 weeks after fear conditioning in the context B (a 
black non-transparent Plexiglas chamber with a planar floor that was cleaned before each 
session with 70% 2-propanol). Freezing behavior was measured as described above. On the 
first and second extinction days, conditioned mice received 12 presentations of the CS (total 
duration 30 s, 1 Hz, white noise, 80 dB, inter-trial interval: 20-60 s). One week after 
extinction, extinguished mice (n=6 per group) were sacrificed for subsequent 
immunohistochemical analysis. In parallel, additional mice (n=25 per each extinction group) 
were tested 7 days after extinction in context B and context A, respectively, using 4 
presentations of the CS (inter-trial interval: 20-60 s) and were further used for the Pearson’s 
correlation analysis of context-dependent spontaneous recovery and fear renewal. 
2.5. Tissue processing for immunohistochemistry 
Animals were deeply anesthetized with CO2 and were transcardially fixed with phosphate 
buffered saline (PBS, pH 7.4) followed by chilled 4% paraformaldehyde (PFA) in PBS. 
Brains were removed from the scull after perfusion, post fixed in 4% PFA overnight at +40C, 
cryoprotected in 30% sucrose, embedded in O.C.T. compound (Tissue-Tek, Sakura, 
Netherlands) and kept at -800C until sectioning. Coronal sections (25 µm thick) were 
performed with a Leica CM3050 S cryostat (Germany). Sections were collected and stored 
in a cryoprotective solution (30% glycerol, 30% ethylene glycol in PBS) at -200C until use. 
2.6. Fluorescent immunohistochemistry  
Immunostaining was performed using free-floating brain sections. After washing with PBS to 
remove the cryoprotective solution, the sections were incubated in a blocking reagent 
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consisting of 5% goat serum (Vector Laboratories, UK), 3% bovine serum albumin (Sigma-
Aldrich, Finland) and 0.4% Triton X-100 (Sigma-Aldrich, Finland) in PBS to prevent 
nonspecific binding of antibodies. Before blocking, an antigen retrieval step including an 
incubation in 0.1% pepsin (Sigma-Aldrich, Finland) in 5 mM HCl for 10 minutes at room 
temperature, was performed to increase the binding of the primary antibodies for 
GABA(A)Rα1, GABA(A)Rα2 and Vglut1. Sections were incubated with one of the primary 
antibodies (Table S1) in PBS containing 0.4% Triton X-100 (PBST) overnight at +4ºC. Then, 
sections were washed in PBST and incubated with the appropriate secondary antibodies 
(Molecular probes, Invitrogen, Espoo, Finland) for 1 hour at room temperature. Finally, 
sections were mounted on slides and covered with Prolong®Gold anti-fade reagent with 
DAPI (Molecular Probes, Invitrogen, Espoo, Finland). Controls “No primary antibody” were 
included in all immunostaining experiments. 
2.7. Image acquisition and processing 
Quantitative evaluation of immunostainings was performed by an investigator blind to the 
treatment groups; all slides were coded until the analyses were finished. The following brain 
regions were analyzed: the prelimbic (PL) and infralimbic (IL) zones of the medial prefrontal 
cortex, basolateral (BLA), lateral (LA) and central (CEA) nuclei of the amygdala, CA1 strata 
oriens (OR), radiatum (RAD), lacunosum-moleculare (LM) and pyramidal layer (PYR) of the 
hippocampus (Fig. S1). The images were obtained by the Imager M.1 fluorescent 
microscope (Zeiss, Germany) using AxioVision software. A minimum of 5 sections per brain 
area/per animal, as well as control sections “No primary antibody”, were imaged using the 
same microscope and camera settings for all slides within each immunostaining experiment. 
DAPI nuclear staining helped to locate and focus on the correct brain areas on the control 
sections “No primary antibody”. Image processing was performed with ImageJ software. To 
estimate the difference in expression of synaptic markers, brain regions were delineated 
(Fig. S2) and mean optical densities were measured. The mean optical densities of the 
controls “No primary antibody” were subtracted from obtained values for every brain area in 
all immunostaining experiments. The resulting values of optical densities were used for a 
Pearson’s correlation analysis, whereas results in Figure 3 and Table S2 are expressed as 
the percentage of the control group CTRL. 
2.8. Statistical analysis 
The values reported in the Tables S2 and S3 and the Figures 1, 3, 5 and S1 represent the 
means ± SEM. Analyses of the behavioral tests were performed using repeated measures 
ANOVA. Statistical analyses of proteins levels from four fear conditioned groups were 
performed using a two-way ANOVA with a post hoc Fisher’s PLSD test. For the protein 
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levels comparison between the control group CTRL and one of the other groups, Student’s 
unpaired two-tailed t-test was used. The bivariate Pearson’s correlation and linear 
regression analyses were performed using Microsoft Excel 2010 and SPSS Statistical 
packages. A P-value of < 0.05 was considered statistically significant. 
 
3. Results 
3.1. Extinction rate correlates with later fear responses 
A two-day fear extinction paradigm (Fig. 1A) has been shown to be effective in the analysis 
of the efficacy of different combinative anti-fear treatments and genotype-specific extinction 
rate in mice (Karpova et al., 2011; Camp et al., 2012). Moreover, during the first day of 
extinction a difference between the control and treatment groups was not always observed. 
However, facilitation of extinction was clearly detected on the second day of training, 
reflecting successful treatment-enhanced extinction retention both in rats and mice (Santini 
et al., 2001; Karpova et al., 2011; Camp et al., 2012). Here we first investigated whether the 
facilitation of fear extinction could be detected in experimental groups with a small number of 
animals (n=6 per group) subjected to further immunohistochemical analysis. Chronic 
fluoxetine treatment after fear acquisition did not significantly affect the freezing levels during 
the extinction day 1 (F1,10=3.60, P=0.087); however, on the second day of extinction 
fluoxetine-treated mice froze significantly less than water-drinking mice (F1,10=5.23, P=0.045) 
(Fig. 1B).  
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Figure 1. Extinction training is effective in combination with the chronic fluoxetine treatment after fear 
conditioning. (A) Experimental protocol. “Fear Cond.” – fear conditioning. Black arrows show the time points for 
samples collection for immunohistochemical analysis of indicated treatment groups. Additional mice from the 
extinguished groups continued behavioral testing until the tests for spontaneous recovery and fear renewal for 
further Pearson’s correlation analysis (shown on the Fig. 2). (B) Behavioral analysis of the mice subjected for 
immunohistochemistry (n=6 per group). Fluoxetine facilitated extinction training in the Extinction Context B. N.S. 
– not significant. *P < 0.05 after repeated measures ANOVA.  
Next, we aimed to analyze if the mouse freezing levels during the extinction days 1 or 2 has 
a long-term predictive validity for its freezing during the tests for spontaneous recovery, SR, 
or fear renewal, FR. We propose that if significant correlations exist 1) between the 
extinction freezing levels and SR/FR responses, and 2) between the synaptic proteins 
expression and extinction freezing levels, then the amount of synaptic proteins in fear-
extinguished animals may have a predictive potential for their SR/FR responses. To better 
calculate the first correlation, we analyzed additional large groups of animals in both SR and 
FR tests (n=25 mice per group). We found that the magnitude of both SR and FR fear 
responses were positively correlated with the averaged (per CS) freezing levels of 
FC+WAT+EXT mice on both the extinction days 1 and 2, with the higher correlation 
coefficients for the extinction day 2 (Fig. 2). Although fluoxetine-treated animals exhibited a 
similar trend, the correlation between their freezing values during extinction and SR or FR 
tasks was not always significant (Fig. 2), possibly because of considerable amount of non-
freezing animals during SR and FR. Together, these behavioral results prompted us to first 
perform a conventional comparison of the mean group levels of synaptic protein expression 
and then perform a Pearson’s correlation analysis of protein levels vs. freezing levels on the 
extinction day 2 in FC+WAT+EXT mice. 
3.2. Synaptic molecular correlates of facilitated extinction 
3.2.1. Synaptophysin  
Synaptophysin, Syp, is a presynaptic vesicles membrane protein important for synaptic 
transmission in neuronal circuits involved in learning and memory. We found that chronic 
fluoxetine did not alter Syp expression after fear conditioning; in contrast, extinction training 
induced Syp expression in almost all brain areas independently of fluoxetine treatment (Fig. 
3 and Table S2). Interestingly, we found no significant Pearson’s correlation between the 
individual freezing levels on the extinction day 2 vs. Syp expression in the FC+WAT+EXT 
group (r<|0.55|, P>0.25), which suggests that the expression levels of this marker of 
presynaptic transmission should not be used as a predictive parameter for fear response.  
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We next determined whether the observed changes in Syp expression levels were 
correlated with the expression of presynaptic markers for excitatory and inhibitory 
transmissions Vglut1 and VGAT.  
 
Figure 2. Freezing responses during extinction positively correlate with the later fear responses as found by a 
Pearson’s analysis between the individual freezing levels of FC+WAT+EXT (open circles, solid line) and 
FC+FLX+EXT (black circles, dash line) mice on the extinction days 1 or 2, EXT d1 or d2, and spontaneous 
recovery, SR, and fear renewal, FR, levels (n=25 per group).  
 
3.2.2. Vglut1 
Fluoxetine treatment did not affect the levels of Vglut1 expression, which was significantly 
reduced by fear conditioning in the hippocampus (Fig. 3 and Table S2). In contrast, the 
effect of fear extinction on Vglut1 levels was fluoxetine-dependent. In almost all brain areas 
of water-drinking animals extinction further decreased Vglut1 expression, whereas fluoxetine 
combined with extinction prevented the decrease in Vglut1 levels and significantly up-
regulated its levels in the lateral and central amygdala of the FC+FLX+EXT mice (Fig. 3). 
The freezing levels on the extinction day 2 were negatively correlated with Vglut1 expression 
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in the CA1 pyramidal layer in the FC+WAT+EXT mice (r=-0.95, P=0.004), suggesting that 
increased hippocampal Vglut1 expression after extinction might be associated with fear 
inhibition. 
 
Figure 3. Long-term effect of fear conditioning, chronic fluoxetine and fear extinction on the expression of 
synaptic markers in the infralimbic (IL) and prelimbic (PL) cortex, basolateral (BLA), lateral (LA) and central 
amygdala (CEA) areas and hippocampal strata oriens (OR), pyramidal (PYR), radiatum (RAD) and lacunosum-
moleculare (LM) layers. OD – optical density. Post hoc analysis: *P < 0.05 vs. CTRL group (dash line at 100% 
level); #P < 0.05 fluoxetine vs. respective water group - FC+FLX vs. FC+WAT and FC+FLX+EXT vs. 
FC+WAT+EXT; §P < 0.05 extinction vs. respective no-extinction group - FC+WAT+EXT vs. FC+WAT and 
FC+FLX+EXT vs. FC+FLX (n=6 per group). 
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3.2.3. VGAT 
The expression levels of VGAT were affected by neither fear conditioning nor extinction in 
fluoxetine-treated animals (Fig. 3 and Table S2). However, VGAT was significantly down-
regulated by fear conditioning in the prelimbic cortex, basolateral amygdala, CA1 pyramidal 
and radiatum areas of FC+WAT mice. Extinction training significantly increased VGAT levels 
in the FC+WAT+EXT group compared with the FC+WAT group in all brain areas except for 
the central amygdala (Fig. 3). Individual VGAT levels were not correlated with freezing levels 
on the extinction day 2 in FC+WAT+EXT mice (r<|0.53|, P>0.28).  
We suggested that the extinction-induced Syp expression might correlate with enhanced 
GABA-ergic or glutamatergic presynaptic transmission in the water or fluoxetine treated 
animals, respectively. To further test this hypothesis, we measured the Pearson’s correlation 
coefficients between the individual levels of Syp and Vglut1 and between Syp and VGAT in 
both extinguished groups of animals. Unexpectedly, there was no correlation between 
increased Syp expression vs. either Vglut1 (FC+WAT+EXT: r<|0.67|, P>0.14; FC+FLX+EXT: 
r<|0.78|, P>0.067) or VGAT (FC+WAT+EXT: r<|0.38|, P>0.45; FC+FLX+EXT: r<|0.45|, 
P>0.37) levels in any of the brain areas analyzed, suggesting that the extinction-induced up-
regulation of these presynaptic proteins was independent of each other. 
3.2.4. Vesicular neurotransmitters transporters along fear extinction circuitry 
We recently showed that chronic fluoxetine combined with extinction training reduced fear 
response in a context-independent manner (Karpova et al., 2011). In the extinction context, 
the infralimbic cortex has been suggested to be activated by the hippocampus and, in turn, 
activates the basolateral amygdala interneurons, which inhibit central amygdala neurons and 
the fear response, whereas in the conditioned context no activation of the infralimbic cortex 
by the hippocampus and, consequently, no fear inhibition occurs (Fig. 4; (Quirk and Mueller, 
2008). The individual mouse Vglut1 levels in the CA1, infralimbic cortex and basolateral 
amygdala and the VGAT levels in the central amygdala may at least partially reflect 
activated or inhibited states of these brain areas. We calculated the correlation coefficients 
between the connections CA1Vglut1 – ILVglut1, ILVglut1 – BLAVglut1 and BLAVglut1 - CEAVGAT in 
extinguished animals and found a strong positive correlation for every connection in only 
fluoxetine-treated mice (Fig. 4). This result might suggest that the combined fluoxetine + 
extinction treatment could reinforce the fear extinction circuitry sufficiently enough to be 
active in both extinction and conditioned contexts. 
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Figure 4. Protein levels correlations between connections CA1VGLUT1 – ILVGLUT1, ILVGLUT1 – BLAVGLUT1 and 
BLAVGLUT1 - CEAVGAT in the fear extinction circuitry of extinguished groups of mice (n=6 per group).  
 
3.2.5. Gat1 
The GABA plasma membrane transporter Gat1 localizes to both neuronal and glial cells 
near synapses and has been shown to restrict GABA spillover at cortical inhibitory synapses 
(Gonzalez-Burgos et al., 2009). We found no significant regulation of Gat1 levels by chronic 
fluoxetine and/or extinction (Fig. 3 and Table S2). However, we observed a strong negative 
correlation between the freezing levels on the extinction day 2 and Gat1 expression in the 
infralimbic (r=-0.94, P=0.005) and prelimbic cortices (r=-0.88, P=0.021) of FC+WAT+EXT 
animals. These results suggest that, in the absence of antidepressant treatment, higher fear 
response after fear extinction may be associated with reduced GAT1 expression. 
3.2.6. Post-synaptic components of GABA-ergic transmission 
Here, we aimed to analyze the expression patterns of two major GABA(A)R subunits, α1 and 
α2, the agonists of which have been associated with sedative and anxiolytic activities, 
respectively (Atack, 2003). 
3.2.6.1. GABA(A)R α1 (sedative) 
The expression of the GABA(A)R α1 subunit was altered by fear conditioning and extinction 
in water-drinking groups of animals: fear conditioning decreased and extinction training 
restored GABA(A)R α1 levels in the infralimbic and prelimbic cortex (Fig. 3 and Table S2). In 
the CA1 pyramidal layer, GABA(A)R α1 expression was down-regulated by fear conditioning 
and restored by extinction to the levels of the CTRL group in both water and fluoxetine-
treated animals (Table S2). Although no significant correlation was found between 
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GABA(A)R α1 levels and the freezing levels on the extinction day 2 in the FC+WAT+EXT 
mice (r<|0.68|, P>0.14), the main effects of extinction training on the increase in GABA(A)R 
α1 were significant in the prefrontal cortex, central amygdala and hippocampal CA1 layers 
(Table S2). 
3.2.6.2. GABA(A)R α2 (anxiolytic) 
In contrast to GABA(A)R α1, GABA(A)R α2 expression was mainly not affected by fear 
conditioning or extinction in water-drinking animals. However, chronic fluoxetine after fear 
conditioning significantly decreased GABA(A)R α2 levels in the prefrontal cortex and CA1 
pyramidal layer (Fig. 3 and Table S2). Moreover, extinction training in the FC+FLX+EXT 
group not only reversed GABA(A)R α2 expression in these brain areas to control levels but 
also markedly up-regulated GABA(A)R α2 levels in the amygdala (Fig. 3). 
Interestingly, despite the finding that fluoxetine treatment combined with extinction increased 
the expression of the GABA(A)R α2 subunit in several brain regions, its levels in the 
amygdala of FC+WAT+EXT mice were positively correlated with their freezing levels on the 
extinction day 2: lateral amygdala (r=+0.814, P=0.049) and central amygdala (r=+0.83, 
P=0.041). Taken together, the effects of the fear conditioning-induced stress and extinction 
training on the expression patterns of GABA(A)R α1 and α2 subunits were dependent on 
whether the animals received fluoxetine treatment or not. 
3.2.7. PSD95, a marker of excitatory post-synaptic transmission 
PSD95 is a major scaffolding protein of the excitatory post-synaptic density. Extinction 
training significantly up-regulated PSD95 levels in the amygdala and, when combined with 
fluoxetine, in all hippocampal layers (Fig. 3, Table S2). Moreover, PSD95 level in the 
basolateral amygdala of FC+WAT+EXT mice was negatively correlated with their freezing 
levels on the extinction day 2 (r=-0.90, P=0.015) further suggesting a role of enhanced 
amygdala PSD95 expression in fear reduction. 
3.2.8. Ionotropic glutamate receptors. GluN2A 
The NMDAR agonist D-cycloserine has been shown to facilitate the extinction of conditioned 
fear (Walker et al., 2002). We were specifically interested whether the beneficial effect of 
chronic fluoxetine on fear extinction was positively associated with the GluN2A subunit of 
NMDARs, which is abundantly expressed in the adult brain. We found that chronic fluoxetine 
after fear conditioning had no effect on GluN2A expression (Fig. 3 and Table S2). However, 
when combined with extinction training, chronic fluoxetine significantly up-regulated GluN2A 
levels in the amygdala areas and in the CA1 pyramidal layer (Fig. 3). Furthermore, the 
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GluN2A levels in the CA1 pyramidal layer of the FC+WAT+EXT mice was negatively 
correlated with their freezing levels on the extinction day 2 (r=-0.84, P=0.036) supporting the 
role of enhanced expression of this subunit in successful erasure of fear memories. 
3.2.9. Ionotropic glutamate receptors. AMPA receptors 
AMPA glutamate receptors play a key role in mediating fast excitatory synaptic transmission. 
We asked whether extinction of conditioned fear in water- or fluoxetine-treated mice alters 
the expression patterns of a Ca2+-permeable GluA1 subunit and the most abundant Ca2+-
impermeable GluA2 subunit of AMPA receptors, which are thought to mediate different 
forms of synaptic plasticity.  
3.2.9.1. GluA1 
We detected significant main effects of extinction training on the reduction of GluA1 
expression in only the CA1 hippocampal areas (Fig. 3 and Table S2). Furthermore, 
fluoxetine treatment further decreased GluA1expression in the CA1 pyramidal layer 
(F1,20=5.26, P=0.033); however, the magnitude of the observed changes was very small. 
3.2.9.2. GluA2 
In contrast to GluA1, the GluA2 subunit showed opposite and more prominent changes in 
the fear circuitry. We observed a significant main effect of the extinction factor on GluA2 up-
regulation in all brain regions analyzed (Fig. 3 and Table S2). Chronic fluoxetine slightly 
increased the GluA2 levels in the CA1 pyramidal layer (main effect of fluoxetine treatment 
F1,20=4.37, P=0.049). Expression levels of both GluA1 and GluA2 subunits in the 
FC+WAT+EXT mice were independent of their freezing levels on the extinction day2 (GluA1: 
r<|0.79|, P>0.062; GluA2: r<|0.67|, P>0.14). 
3.2.9.3. GluA1:GluA2 ratio 
The reduced GluA1:GluA2 ratio in the nucleus accumbens of stress-resilient mice has been 
suggested to decrease glutamatergic transmission and, thus, to be protective against the 
deleterious effects of stress (Vialou et al., 2010). We analyzed here how a stress-resilient 
state of AMPA receptors in fear circuitry was affected by fluoxetine and/or extinction training. 
Stress induced by fear conditioning increased the GluA1:GluA2 ratio in only the CA1 
pyramidal layer in FC+WAT mice (Fig. 5 and Table S3). In contrast, extinction significantly 
down-regulated the ratio in all brain areas analyzed. Fluoxetine treatment additionally 
reduced the GluA1:GluA2 ratio in the CA1 pyramidal layer (F1,20=5.93, P=0.024), although 
the magnitude of this effect was minor (Fig. 5).  
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Figure 5. Extinction training decreases the GluA1:GluA2 ratio in the fear circuitry. Post hoc analysis: *P < 0.05 
vs. CTRL group; #P < 0.05 fluoxetine vs. respective water group - FC+FLX vs. FC+WAT and FC+FLX+EXT vs. 
FC+WAT+EXT; §P < 0.05 extinction vs. respective no-extinction group - FC+WAT+EXT vs. FC+WAT and 
FC+FLX+EXT vs. FC+FLX (n=6 per group). 
 
4. Discussion 
In the present study we show that a combination of fluoxetine and extinction treatments 
forms a specific synaptic landscape permissive for long-term fear extinction facilitation and 
fear erasure in adult mice. In addition, our immunohistological approach, in parallel with the 
behavioral assessments of fear-conditioned mice, provides novel findings on the synaptic 
profiles of more efficient fear reduction by extinction in control water-drinking animals. The 
key findings are summarized in Table 1. 
 
4.1. Synergic and distinct long-term synaptic modifications induced by fear acquisition 
in water- and fluoxetine- treated mice 
Hippocampal synaptic protein (synapsin and synaptophysin) loss has been described in a 
mouse model of posttraumatic stress disorder (Herrmann et al., 2012). We found that stress 
induced by fear conditioning had a long-lasting inhibitory effect on the expression of pre- and 
postsynaptic components of inhibitory and excitatory transmissions (Syp, GABA(A)R α1 and 
GluA2 receptors) in the hippocampal CA1 pyramidal layer and in the whole hippocampus 
(Vglut1) of both water- and fluoxetine-treated conditioned animals. Neuronal excitotoxicity 
due to GluA2 dysfunction and the subsequent increase in Ca2+-permeability of AMPAR has 
been associated with motor neurons loss (Van Damme et al., 2002). However, the 
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hippocampal GluA2 reduction observed in our study was modest in comparison with the 
reduced Vglut1 expression throughout the brain of the fear conditioned mice regardless of 
fluoxetine treatment. The expression pattern of Vglut1 suggests that glutamatergic 
transmission was inhibited at the presynaptic level by fear conditioning, which could mediate 
anxiety-like symptoms in the absence of extinction training. Indeed, reduced glutamate 
function due to Vglut1 deficiency (Wojcik et al., 2004) has been linked to impaired LTP, 
learning and memory (Balschun et al., 2010) and depression- and anxiety-like behaviors 
(Tordera et al., 2007).  
What molecular mechanisms could accelerate fear extinction in fluoxetine-drinking animals? 
We found that expression levels of pre- and postsynaptic markers of inhibitory transmission 
were dependent on fluoxetine treatment. The decrease in GABA-receptors function has 
been specifically implicated in anxiety- and fear-related disorders (Luscher et al., 2011). In 
contrast, to our knowledge no studies exist that analyze the presynaptic markers of inhibitory 
transmission in development of fear memories, although a decreased expression of the 
vesicular GABA and glycine transporter, VGAT, has been recently associated with cold 
water swim stress-induced anxiety (Schoenfeld et al., 2013). Similarly, in our study, stress 
induced by fear conditioning reduced VGAT expression but only in water-drinking mice. At 
the GABA-receptor level, we found that the sedation-associated GABA(A)R α1 subunit was 
primarily down-regulated in water-drinking mice; in contrast, the anxiolytic GABA(A)R α2 
subunit expression was primarily decreased in fluoxetine animals. To date, this is the first 
study that suggests a role for GABA(A)R α2 in the facilitation of fear extinction by fluoxetine. 
Consistent with our findings, the distinct role of α1- and α2- containing GABA(A)Rs in 
sensitivity to benzodiazepines treatment and expression of anxiety responses has been 
revealed using transgenic mice with reduced levels of either subunit (Smith et al., 2012; 
Koester et al., 2013). These results and our findings expand the previous knowledge about 
decreased GABA-ergic tones following fear conditioning (Chhatwal et al., 2005; Ehrlich et 
al., 2009; Mahan and Ressler, 2012) and a GABA-ergic deficit hypothesis of 
neuropsychiatric disorders (Luscher et al., 2011). 
Antidepressant fluoxetine reactivated the ocular dominance plasticity in the adult visual 
cortex and induced the structural rearrangement of inhibitory circuits providing a mechanism 
for experience-dependent plasticity in response to visual deprivation (Chen et al., 2011). Our 
findings on the distinct changes in the inhibitory system produced by fluoxetine after fear 
conditioning suggest that fluoxetine treatment may promote a permissive remodeling at the 
synaptic structural level that would facilitate circuit-specific modifications in response to an 
environmental stimulus such as extinction training. 
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Table 1 Summary of the key synaptic protein changes induced by each type of treatment following fear conditioning 
in the prefrontal cortex, amygdala and hippocampus  
Treatment No treatment 
(FC+WA
T)# 
Fluoxeti
ne only 
(FC+FLX) 
Extinction 
only 
(FC+WAT+EX
T) 
Fluoxetine+Extincti
on 
(FC+FLX+EXT) 
Marker 
Syp   
All brain areas
↑ 
All brain areas↑ 
Components of excitatory transmission 
Vglut1 Hippo ↓ Hippo ↓ 
All brain areas 
↓ 
Amy ↑, Hippo ↑* 
PSD95   Amy ↑ Amy, Hippo ↑↑ 
GluN2A    Amy ↑ 
GluA1:Glu
A2 
  
All brain areas 
↓ 
PFC, Amy ↓, Hippo 
↓↓ 
Components of inhibitory transmission 
Gat1   PFC↗  
VGAT 
All brain 
areas ↓ 
 
All brain areas 
↑ 
 
GABA(A)α1 PFC ↓  PFC ↑* Amy ↑ 
GABA(A)α
2 
 PFC ↓ Amy↘ PFC ↑*, Amy ↑↑ 
PFC - prefrontal cortex; Amy - amygdala; Hippo - CA1 area of the hippocampus 
↓- decreased, ↓↓- strongly decreased, ↑- increased, ↑↑- strongly increased and ↑*- restored to control level 
protein expression 
PFC↗ and Amy↘ indicate elevated (↗) or decreased (↘) protein expression in the lower-freezing FC+WAT+EXT 
mice as determined by a Pearson’s correlation analysis of protein levels vs. freezing levels on the extinction day 2 
# Upper row: the groups are indicated in parentheses 
 
4.2. Long-term synaptic modifications in water- and fluoxetine treated mice in 
response to extinction training 
An increasing amount of studies provide evidence that the extinction of conditioned fear may 
represent both 1) a depotentiation of synapses that were potentiated after fear conditioning 
and 2) a new learning while the fear acquisition memories remain intact (Myers and Davis, 
2007; Hong et al., 2009). We found that the inhibitory influence of fear acquisition on the 
expression of several synaptic proteins was primarily neutralized in a week after extinction, 
18 
 
which is consistent with both hypotheses of extinction. Indeed, the reversal of original protein 
expression might happen at the synapses that were lastingly affected by fear conditioning. 
Alternatively and/or simultaneously, some long-term extinction-induced synaptic changes 
may involve new synapses or circuits resulting in restored or up-regulated total protein 
levels. In line with previous studies on enhanced synaptic densities and transmissions by 
extinction (Heldt and Ressler, 2007; Lin et al., 2010), we found that extinction training 
increased total protein levels of Syp, PSD95, the sedation-associated GABA(A)R α1 subunit 
and the GluA2 receptor, suggesting enhanced excitatory and inhibitory synaptic plasticity in 
both water- and fluoxetine-treated mice. Moreover, our results suggest that extinction 
training alone may promote AMPA-receptors re-composition in the fear memory network to 
more stress-resilient state (Vialou et al., 2010). These data suggest common mechanisms of 
extinction-induced excitatory and inhibitory plasticity independent of fluoxetine treatment. 
How does chronic fluoxetine combined with extinction subsequently reduce fear memories 
(this study and (Deschaux et al., 2011; Karpova et al., 2011; Camp et al., 2012)? Does the 
combined treatment 1) enhance synaptic changes produced by extinction in water-treated 
animals or 2) promote unique alterations in synaptic proteins expression? To support the first 
hypothesis, we found that consolidation of extinction memories might benefit from the 
combined treatment by a decrease in GluA1:GluA2 ratio in the CA1 pyramidal layer (see 
also (Vialou et al., 2010); however, the effect of fluoxetine was minor and seems unlikely to 
mediate a robust behavioral effect on fear erasure.  
In contrast, our data provide more evidence for a unique long-lasting remodeling of synaptic 
protein expression profiles as a result of the combined treatment. D-cycloserine, an NMDA-
receptor partial agonist, has been consistently shown to facilitate extinction (Walker et al., 
2002; Lin et al., 2010), which is in agreement with our findings on enhanced GluN2A 
expression with the combined treatment. In addition, the patterns of the presynaptic markers 
Vglut1 (decreased) and VGAT (increased) showed that extinction favored towards inhibitory 
transmission in water-drinking mice and this effect was prevented by fluoxetine. The level of 
VGAT expression correlates with the release of the inhibitory neurotransmitters GABA, 
glycine and potentially beta-alanine (Wojcik et al., 2006; Juge et al., 2013), and our data 
suggest that extinction training potentiated GABA release from presynaptic terminals in the 
water group. In contrast, increased Vglut1 expression in the amygdala or hippocampal areas 
of fluoxetine mice implicates enhanced glutamate release in fear reduction by extinction. A 
plausible explanation of these extinction-induced presynaptic changes could be a 
potentiation of inhibitory drive onto fear neurons (Ehrlich et al., 2009; Vlachos et al., 2011) in 
the water group and of excitatory drive onto extinction neurons in the fluoxetine group. In 
addition, we found strong positive correlations between Vglut1 levels in the fear circuitry 
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CA1- infralimbic cortex - basolateral amygdala and the VGAT level in the central amygdala 
specifically in FC+FLX+EXT mice. These data might implicate simultaneous increase of 
glutamatergic transmission along the fear network in sustained inhibition of the central 
amygdala neurons after extinction (Quirk and Mueller, 2008) observed in only fluoxetine-
treated mice. Because we analyzed only the major brain areas involved in the formation of 
fear memory, this suggestion needs further experimental validation with more molecular 
markers and anatomical connections that each brain area forms.  
To date, a brain-derived neurotrophic factor, Bdnf, represents the most studied signal 
transmitter in the fear network. Bdnf-containing inputs from the hippocampal CA1 to the 
infralimbic cortex mediate the efficacy of fear extinction (Heldt et al., 2007; Peters et al., 
2010), and basolateral amygdala Bdnf signaling is important for fear reduction by extinction 
(Chhatwal et al., 2006; Karpova et al., 2011). Bdnf deficiency weakens hippocampal Bdnf-
inputs (Chen et al., 2006) and results in extinction impairment (Soliman et al., 2010) 
independently of fluoxetine treatment (Karpova et al., 2011). Potential synaptic mechanisms 
of this impairment might involve Bdnf-dependent control of Vglut1 expression and glutamate 
release in LTP (Melo et al., 2013) impaired in the hippocampus of Bdnf-deficient mice 
(Patterson et al., 1996). 
A unique feature of the prefrontocortical GABA-ergic transmission has been detected in 
FC+WAT+EXT mice. Specifically we found a strong negative correlation between Gat1 
expression and freezing levels on the second extinction day. The reduced cortical GAT1 
levels implicated an increased GABA spillover in the prolongation of IPSP duration, which is 
critical for timing of GABA-ergic inhibition during network oscillation (Gonzalez-Burgos et al., 
2009). Prolonged IPSP may lead to overlaps in time of GABA-ergic inputs from distinct 
interneurons and thus perturb cell-type specific inhibition during inhibitory learning 
(Gonzalez-Burgos et al., 2009) such as extinction. Therefore, the reduced cortical Gat1 in 
higher-freezing mice may predict subsequent higher fear response in water-drinking mice, 
an effect absent in mice after combined treatment.  
A strengthened inhibitory transmission has been shown to play a critical role in fear 
extinction memories (Chhatwal et al., 2005; Quirk et al., 2010). Consistent with this view, we 
found that extinction essentially restored conditioning-induced deficits of the GABA(A)R α1 
or α2 subunits in the water- or fluoxetine-group, respectively. It’s possible that chronic 
fluoxetine treatment reshapes the fear memory network and promotes structural remodeling 
of inhibitory circuits (Chen et al., 2011) so the anatomical location of GABA(A)R α2-
containing receptor subtypes functions to facilitate the inhibitory input to the fear-associated 
neurons during or after extinction. In line with this suggestion, a recent study demonstrated 
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specific IPSP kinetics expressed by interneurons with different GABA(A)R subunits (Eyre et 
al., 2012). Moreover, GABA(A)Rs  with different α subunits preferentially localize in distinct 
cellular compartments in cortical and hippocampal neurons (Fritschy and Mohler, 1995; Volk 
et al., 2002), although to our knowledge no data exist about GABA(A)R α1 and α2 
subcellular localization in amygdala nuclei. Recently, the subcellular distribution of key 
plasticity-related molecules, such as Bdnf, has been shown to play a critical role in learning 
and memory (Chiaruttini et al., 2009), and further studies should provide better insight into 
the function of the anatomical location of different GABA(A)R subtypes in fear extinction 
learning. 
4.3. Conclusions 
Our data demonstrate that a combination of chronic fluoxetine with extinction training forms 
a specific synaptic proteins profile associated with an animal’s ability to cope with fear during 
recovery/renewal/reinstatement tasks. Our findings that fluoxetine treatment together with 
extinction comprises the effects of the NMDAR- and GABA(A)R-potentiating drugs in a 
subunit- and brain area-specific manner provide a background for further optimization of 
fear-reducing therapeutic approaches. In this study, we analyzed only a portion of the 
immense synaptic machinery and in only a few critical brain regions. Future studies should 
elucidate 1) the synaptic mechanisms of currently used effective pharmacological and non-
pharmacological enhancers of fear extinction, 2) whether other SSRIs share a similar 
potential and mechanisms of extinction facilitation with fluoxetine, 3) how long after 
discontinuation of fluoxetine exposure the efficacy of the combined treatment persists, and 
4) whether human polymorphism in one of the most critical genes described here may 
underlie a possible failure of the combined therapy in the treatment-resistant patients.  
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